Fischer Benedikt, Rehm Jürgen, Kirst Maritt, Casas Miguel, Hall Wayne, Krausz Michael, Metrebian Nicky, Reggers Jean, Uchtenhagen Ambros, van den Brink Wim, van Ree Jan M
Department of Public Health Sciences, University of Toronto, McMurrich Bldg., 109C, Toronto, ON, M5S 1A8, Canada.
Eur J Public Health. 2002 Sep;12(3):228-34. doi: 10.1093/eurpub/12.3.228.
Injection drug use (involving the injection of illicit opiates) poses serious public health problems in many countries. Research has indicated that injection drug users are at higher risk for morbidity in the form of HIV/AIDS and Hepatitis B and C, and drug-related mortality, as well as increased criminal activity. Methadone maintenance treatment is the most prominent form of pharmacotherapy treatment for illicit opiate dependence in several countries, and its application varies internationally with respect to treatment regulations and delivery modes. In order to effectively treat those patients who have previously been resistant to methadone maintenance treatment, several countries have been studying and/or considering heroin-assisted treatment as a complementary form of opiate pharmacotherapy treatment. This paper provides an overview of the prevalence of injection drug use and the opiate dependence problem internationally, the current opiate dependence treatment landscape in several countries, and the status of ongoing or planned heroin-assisted treatment trials in Australia, Canada and certain European countries.
